Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?

Douglas L. Mann, Daniel P. Kelly

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)355-357
Number of pages3
JournalJACC: Basic to Translational Science
Issue number4
StatePublished - Aug 2017


  • SGLT
  • cardiovascular disease
  • diabetes mellitus
  • empagliflozin
  • sodium glucose transport inhibitor

Cite this